American Thoracic Society International Conference

There has been increasing use of and research on home-based pulmonary rehabilitation during the COVID-19 pandemic, bringing to light numerous benefits of telehealth rehabilitation along with traditional center-based rehabilitation.

Patients with COPD who received care in an accredited advanced COPD center of excellence clinic had lower ED use compared with those who received care at another center, researchers reported.

Full pulmonary function tests contribute useful diagnostic information for evaluating patients with vaping-related lung injury, according to a speaker at the American Thoracic Society International Conference.

In this video, Michael E. Wechsler, MD, MMSc, presents results of a post hoc analysis that evaluated long-term maintenance of oral corticosteroid reduction with dupilumab.

In a preliminary analysis of the ongoing SPECTRA study, patients with pulmonary arterial hypertension treated with sotatercept had improvements in hemodynamics, exercise capacity and 6-minute walk distance.

Long-term treatment with dupilumab helped patients with oral corticosteroid-dependent asthma wean their oral corticosteroid use and also reduced exacerbations and improved lung function.

In the U.S., mortality trends in patients with pulmonary arterial hypertension continue to improve; however, rates remain high in those with intermediate- and high-risk characteristics, researchers reported.

Younger adults with COPD have elevated rates of health care utilization and excess mortality, researchers reported.

A home-based exercise training program for patients with COPD after pulmonary rehabilitation was associated with high adherence and a benefit in functional exercise capacity but no change in dyspnea from baseline to 1 year.

New data from the phase 3 TYREE study demonstrate efficacy of a fixed-dose combination of budesonide and albuterol in a single pressurized metered-dose inhaler to prevent exercise-induced bronchoconstriction in individuals with asthma.